Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 334 across all filing types
Latest filing 2022-03-31 Regulatory Filings
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO and CFO of NeonMind Biosciences Inc. It certifies the review and fair presentation of the annual filings for the financial year ended November 30, 2021. The document explicitly states it is a certification and does not contain the actual annual report or financial statements. It is a regulatory certification document related to annual filings, not the filings themselves. The document length is short (3159 characters) and it is primarily an officer certification. According to the rules, such certification documents should be classified as Regulatory Filings (RNS), not as the Annual Report (10-K) or other financial reports.
2022-03-31 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management Discussion and Analysis' (MD&A) for the years ended November 30, 2021 and 2020. It discusses the company's financial position, performance, business overview, strategies, and future outlook. It references audited financial statements but does not itself contain full financial statements or detailed financial data. The MD&A is a narrative report typically accompanying annual or interim financial reports, providing management's perspective on the financial results and business conditions. Given the length (15,000 characters) and content focused on management's discussion rather than just an announcement or certification, this document fits the category of Management Reports (MDA). It is not an Annual Report (10-K) because it lacks full financial statements and comprehensive annual reporting. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive discussion and analysis, not just an announcement or certification. Therefore, the appropriate classification is MDA with high confidence.
2022-03-31 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 90% confidence The document text is mostly garbled, contains non-standard characters, and does not provide any clear financial data, report titles, regulatory references, or meaningful content. The length is only 2721 characters, which is quite short and suggests it is not a full financial report. There is no indication of actual financial statements, management discussion, or detailed disclosures. The text does not resemble any specific report type such as Annual Report, Interim Report, Earnings Release, or any other defined category. Given the lack of meaningful content and the presence of corrupted or placeholder text, the best classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous or unclear filings.
2022-03-31 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 95% confidence The document is an Independent Auditor's Report for NeonMind Biosciences Inc. covering the financial statements for the years ended November 30, 2021 and 2020. It includes detailed audit opinions, financial statements such as statements of financial position, operations, changes in shareholders' equity, and cash flows. The presence of an auditor's opinion, detailed financial data, and notes to the financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length (15,000 characters) and content confirm it is not a brief announcement or certification but a full audit report. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2021
2022-03-31 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 90% confidence The document text is mostly garbled, containing unintelligible characters and corrupted data, with no clear indication of any specific report type, regulatory body, or financial period. There are no recognizable keywords or phrases that would suggest it is an Annual Report, Earnings Release, Call Transcript, or any other specific filing category. The document length is about 5806 characters, but the content does not contain substantive financial data or meaningful text. Given the lack of identifiable content and the corrupted nature of the text, the best classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous or unclear filings.
2022-03-31 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from NeonMind Biosciences responding to a request from OTC Markets regarding promotional activity related to the company's shares. It discusses marketing efforts, promotional newsletters, trading activity, and clarifies share issuance practices. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement addressing regulatory inquiries and investor relations matters rather than a financial report or formal filing. It does not fit into categories like Annual Report, Earnings Release, or Interim Report. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2022-03-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.